APYX
Apyx Medical Corp
NASDAQ · Healthcare · Medical - Devices · US
$3.06
+0.99%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$3.03
From 52W high−37.04%
Volume152657.00
Market cap$128.90M
P/E (TTM)—
P/S (TTM)2.2x
Div yield—
Key dataSep 18, 2026
Open
$3.03
From 52W high
−37.04%
Volume
152657.00
Market cap
$128.90M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−86.3x
P/E (TTM)
—
RSI (14)
41.5
MomentumView details →
1D Return
+0.99%
YTD Return
−13.57%
SummaryUpdated Jun 1, 2026
Apyx Medical Corporation (NASDAQ:APYX) is a Florida-based medical device company that was founded in 1982 and originally operated under the name Bovie Medical Corporation before rebranding in January 2019. The company specializes in developing, manufacturing, and selling advanced energy-based medical devices primarily for the cosmetic surgery and surgical markets worldwide. Apyx went public in January 2019 and has positioned itself as a technology leader in the growing aesthetic medicine sector, particularly focusing on minimally invasive procedures for skin tightening and body contouring.
Similar companies
Latest newsMore news →